position: EnglishChannel > Visual Stories > Article

ICGEB Accepted 20,000 Protective Face Masks Donation from Chinese Partners

Source: International Union for Science and Technology Communication| 2020-05-18 13:46:55| Author: ICGEB


The picture shows thatDr. Lawrance Banks(L) is distributing protective masks from China to the localhealth authorities in Trieste, Italy.

The International Center for Genetic Engineering and Biotechnology (ICGEB) is collaborating on many fronts with its partners in China, and in particular, with  China Medical City (CMC), Taizhou, location of the ICGEB Regional Research Centre, and the China National Center for Biotechnology Development (CNCBD), the branch of the Chinese Ministry of Science and Technology that is responsible for ICGEB in Beijing, China.

Dr. Lawrence Banks, ICGEB Director-General said:"In a wonderful show of international solidarity, medical equipment including 20,000 protective face masks, have been donated from our friends and colleagues in China, and were delivered to the ICGEB Trieste on 23 April 2020. ICGEB has liaised with the Italian Regional Health Authority to ensure distribution of the masks to local health authorities."

The ICGEB in Trieste, Italy has received a consignment of protective masks from its Chinese partners in Beijing and Taizhou.

Editor:余昊原

Top News

  • By the end of July, China had increased its daily nucleic acid testing (NAT) capacity to 4.84 million. A total of 4,946 medical institutions, manned by more than 38,000 technicians, are now capable of conducting the test to identify the presence of COVID-19.

Researchers discover mechanism that makes COVID-19 more severe in diabetics

Brazilian researchers have discovered one of the causes of severe COVID-19 in diabetic patients. Laboratory experiments showed that the higher level of blood sugar in these patients is captured by monocytes, a type of defense cell, and serves as a source of additional energy for the coronavirus to replicate more than in a healthy organism. In response to the increased viral load, the monocytes release large amounts of pro-inflammatory cytokines with several effects including lung cell death.

A Future to Expect: International S&T Community Expresses High Hope in Cooperation with Peers in China

According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category. The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.

Copyright © Science and Technology Daily, All Rights Reserved

mailto: yuhy@stdaily.com